Danielle Buda
Psychiatry · Lincoln, NENPI 1205944949
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 390 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AbbVie at 52.5% of the total.
Across 390 payments — averaging $13.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Lundbeck LLC$671
- Otsuka America Pharmaceutical, Inc.$477
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$452
- Johnson & Johnson$245
- Takeda Pharmaceuticals U.S.A., Inc.$187
- plus $433 from 8 others
What the payments were for
- Food & beverage$5,12299%
- Education$611%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 225 | $2,720 |
| Lundbeck LLC | 55 | $671 |
| Otsuka America Pharmaceutical, Inc. | 34 | $477 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 28 | $452 |
| Johnson & Johnson | 9 | $245 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $187 |
| Axsome Therapeutics, Inc. | 7 | $123 |
| Neos Therapeutics, LP | 6 | $99 |
| Azurity Pharmaceuticals, Inc. | 4 | $61 |
| Idorsia Pharmaceuticals US Inc | 3 | $50 |
| Sunovion Pharmaceuticals Inc. | 3 | $39 |
| Alkermes, Inc. | 2 | $29 |
| Ironshore Pharmaceuticals Inc. | 1 | $18 |
| Bausch Health US, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$124
How this compares
$5,184 in reported general payments places this provider in the 85th percentile of 160 psychiatry providers in Nebraska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelsomraSuvorexant | 13 | $5,793 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 58 | $2,164 |
| Duloxetine Hcl | 50 | $1,182 |
| Lamotrigine | 77 | $558 |
| Gabapentin | 73 | $530 |
| Lorazepam | 63 | $523 |
| Escitalopram Oxalate | 35 | $444 |
| Bupropion XlBupropion Hcl | 23 | $435 |
| Olanzapine | 20 | $394 |
| Clonazepam | 39 | $385 |
| Bupropion Hcl SrBupropion Hcl | 23 | $374 |
| Buspirone Hcl | 32 | $335 |
| Ziprasidone Hcl | 12 | $327 |
| Sertraline Hcl | 33 | $282 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 22 | $269 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Lincoln
- Walter DuffyLincoln$46K
- Dianna ClyneLincoln$19K
- Jeffrey CoffmanLincoln$18K
- Kelli BremerLincoln$13K
- Rajeev ChaturvediLincoln$6K
- Ryan SantinLincoln$2K
- Andi NgoLincoln$1K
- Jessica BuettnerLincoln$1K
- Sanat RoyLincoln$794
- William MichaelLincoln$289
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.